The CDC identified the novel H1N1 influenza virus
On Apr. 15, 2009, the U.S. Centers for Disease Control and Prevention (CDC) identified the novel H1N1 influenza…
Vaccine Court ruled that MMR vaccine does not cause autism
On Feb. 12, 2009, the Vaccine Court ruled that MMR vaccine, when administered with thimerosal-containing vaccines, does not…
Francoise Barre-Sinoussi was awarded a share of the Nobel Prize in Physiology or Medicine for the discovery of the human immunodeficiency virus
On Oct. 6, 2008, Francoise Barre-Sinoussi was awarded a share of the 2008 Nobel Prize in Physiology or…
The first HIV case in history was recognized
Jun. 25, 2008, researchers reported that the human immunodeficiency virus (HIV-1) responsible for most of the AIDS cases…
Biotechnology | FDA | Polio | Vaccine
FDA approved new DTaP-IPV vaccine (Kinrix) for use in children ages 4-6 years
On Jun. 24, 2008, the U.S. Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoid…
Biotechnology | FDA | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had licensed Pentacel, Diphtheria…
FDA approved new rotavirus vaccine for use in U.S.
On Apr. 3, 2008, the U.S. Food and Drug Administration (FDA) approved new rotavirus vaccine (Rotarix) for use…
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
CDC | Diagnostics | Influenza | Therapeutics
The Influenza Reagent Resource was established by the CDC
In 2008, the Influenza Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC)…
The University of Missouri Research Animal Diagnostic Laboratory was opened
In 2008, the University of Missouri Research Animal Diagnostic Laboratory opened its new $15.5 million facility at Discovery…
The National Institutes of Health established Human Microbiome Project
On Dec. 19, 2007, the Human Microbiome Project (HMP), a $150 million initiative, was established by the National…
CDC published updated recommendations for prevention of hepatitis A virus infection
On Oct. 19, 2007, the U.S. Centers for Disease Control and Prevention (CDC) published updated recommendations for prevention…
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
Biotechnology | COVID-19 | Diagnostics | Disease | Influenza | Plague | Therapeutics | Vaccine
Fort Knox prepared for pandemic outbreak scenarios
On Jun. 7, 2007, years before the COVID-19 pandemic swept across the globe, a group of about 100…
Biotechnology | CDC | Influenza | Therapeutics | Vaccine
Human infection with a novel influenza virus was added to the nationally notifiable disease list
On Jan. 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists approved an interim…
The first significant outbreaks of ZIKV infection involving more than a few persons were detected
In 2007, the World Health Organization (WHO) reported the first significant outbreaks of Zika virus infection involving more…
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
Biotechnology | CDC | Diagnostics | Influenza | Vaccine
CDC stopped recommending adamantanes during 2005 season after high levels of influenza A (H3N2) virus resistance
On Jan. 17, 2006, the Centers for Disease Control and Prevention (CDC) announced that it had stopped recommending…
The CDC’s advisory Committee recommended routine immunizations for children and adolescents of rotavirus and HPV
On Jan. 6, 2006, the U.S. Centers for Disease Control and Prevention’s (CDC) advisory Committee on Immunization Practices…
CDC’s ACIP updated immunization strategy to eliminate transmission of Hepatitis B Virus infection in the U.S.
On Dec. 23, 2005, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
CDC announced that rubella was no longer endemic in the U.S.
On Mar. 21, 2005, the U.S. Centers for Disease Control and Prevention (CDC) announced that a major public…
UI Microbiology Professor Mark Stinski made the discoveries of CMV promoter and was named Iowa Inventor of the Year
On Sept. 30, 2003, University of Iowa (UI) Microbiology Professor Mark Stinski made the discoveries of CMV promoter…
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
The first nasally administered influenza vaccine (FluMist by MedImmune) was licensed
On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…
Biotechnology | Disease | HIV | Vaccine
U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established
On Jan. 26, 2003, President Bush, in his State of the Union Address, announced the Emergency Plan for…
Public health officials were concerned about re-emergence of H5N1 avian influenza
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
Biotechnology | Disease | FDA
Genentech drug Pegasys (peginterferon alfa-2a) approved
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…